SEC Filing Analysis: Voyager Therapeutics, Inc. (VYGR)

Executive Summary

• Trading Significance: Low
• Key Takeaway: The President and CEO of Voyager Therapeutics conducted a minor, non-discretionary sale of stock to cover tax liabilities arising from the vesting of restricted stock units (RSUs).
• Market Impact: Neutral. This transaction is automated and procedural, carrying no new information for investors.

Company Information

Field	Value
Company	Voyager Therapeutics, Inc.
Ticker Symbol	VYGR
CIK	0001640266
Industry	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES)

Insider Information

Field	Value
Name	Sandrock Alfred
CIK	0001577061
Title/Position	President and CEO
Relationship	Director, Officer

Transaction Details

Field	Value
Form Type	4
Transaction Date	2026-02-10
Transaction Code	S (Sale)
Security Type	Common Stock
Shares Involved	12,192
Price Per Share	$3.78 (Weighted Avg)
Total Value	$46,085.76
Shares Owned After	509,989
Ownership Type	Direct

Financial Impact Assessment

Transaction Materiality

Metric	Value
Transaction Value	$46,085.76
% of Market Cap	0.021%
Shares Transacted	12,192
% of Shares Outstanding	0.022%
Post-Transaction Ownership	509,989 shares (0.92% of outstanding)
Materiality Assessment	Low

Impact Evaluation

• Market Cap Context: The $46k transaction is negligible compared to Voyager's $220 million market capitalization, representing only 0.021% of its value.
• Ownership Concentration: The sale represents a very small fraction of the CEO's holdings. Post-transaction, the CEO still owns a significant stake of 509,989 shares, or 0.92% of the company.
• Transaction Significance: The transaction's size relative to both market cap and shares outstanding is well below the thresholds for moderate significance. The non-discretionary nature further reduces its importance.

Market Impact Analysis

Stock Impact Prediction

• Direction: Neutral
• Reasoning: The filing explicitly states this is an automatic sale to cover tax obligations related to RSU vesting. Such transactions are common, planned, and do not reflect an insider's discretionary investment decision or outlook on the company's future performance.

Volume & Sentiment

• Expected Volume Impact: Negligible. The trade size is too small to impact trading volume in any meaningful way.
• Sentiment Indicator: Neutral. This is a procedural financial management activity, not a market-moving event.

Additional Context

Transaction Notes

• Special Circumstances: The filing's footnote clarifies this was a "sell-to-cover" transaction to satisfy tax withholding obligations and was executed via a durable automatic sales instruction letter. It is explicitly noted as not being a discretionary trade by the reporting person.